X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Tjoapack expands pre-filled pharma packaging

Content Team by Content Team
12th October 2020
in News, Packaging & Logistic
Tjoapack expands pre-filled pharma packaging

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The contract pharmaceutical packaging firm plans to add automated packaging equipment to help meet growing demand for pre-filled syringes and vials.

Based in the Netherlands, contract packaging organization (CPO) Tijoapack plans to add an automated packaging line to handle vials and syringes. The company expects to hit the ‘start’ button on the vial packaging line in the first quarter of 2021, and the pre-filled syringes (PFS) line in the fourth quarter of 2021.

Tjoapck CEO Dexter Tjoa told Outsourcing-Pharma that COVID-19 has created an impact on the pre-filled market.

“The prefilled syringes market is impacted due to the pandemic, resulting in the impact of the pandemic on drug manufacturing and supply chain is expected to affect the market for the short term?,” he said.

Additionally, Tjoa told us, surges in chronic conditions such as diabetes are one of the factors driving growth.

“Prefilled syringes are mainly used for the treatment of chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications?,” he informed us. “As a result, the increasing incidence and prevalence of chronic and lifestyle diseases across the globe is a major factor contributing to the growth of the prefilled syringes market; moreover, there is a growing demand for self-injection devices, considering the convenience and safety associated with their use?.”

According to the company, the PFS line will feature an initial capacity of 7m syringes annually. The line will be configured to assemble and automate insertion of plunger rods and backstops, carry out inline labeling, and offer coding and vision control.

The new packaging capabilities come after a recent investment in Tjoapack by healthcare-focused private equity firm Ampersand Capital Partners.

“At Tjoapack we’re committed to ensuring we consistently bolster our offering and deliver the efficient and flexible services that our clients expec?t,” Tjoa said. “The investment from Ampersand allows us to build on our strong foundations, expand our service offering, and ensure we continue to meet customer demand?.”

“Our vision is to shape the pharmaceutical supply chain to be safer and more efficient and, as a result, enable our clients to make the world healthier by facilitating their life sciences research, production and delivery of medicines to patients across the globe?,” he added.

Tjoa also commented that developments in therapies for chronic diseases that call for injectables will continue to impact demand.

“As new therapies emerge to address unmet patient needs for chronic ailments the demand for contract packaging organization that can handle syringes and vials will continue to rise?,” he commented. “Technological advancements, improving patient compliance, beneficial reimbursement policies, and the rise of biologics in the pharmaceutical market will also further propel the needs for service providers who can meet these requirements.?”

Previous Post

Eisai Enters Joint Development Agreement for COVID-19 Therapeutics

Next Post

CureVac initiates Phase 2a clinical trial of COVID-19 vaccine candidate

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial

CureVac initiates Phase 2a clinical trial of COVID-19 vaccine candidate

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In